LobbyingEuroapi lobbying by quarter
Euroapi's latest lobbying report covers Q2 2024, at under $5,000. Its first report covers Q1 2023; the issues it reports most are Health Issues and Manufacturing.
Euroapi
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $50K | 1 |
| Q2 2023 | $80K | 1 |
| Q3 2023 | $80K | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Health issues4 reports
- Manufacturing4 reports
- Pharmacy4 reports
A report that names several issues counts once for each.
Who was lobbied
- Health & Human Services, Dept of (HHS)3 reports
- HOUSE OF REPRESENTATIVES3 reports
- Office of Science & Technology Policy (OSTP)3 reports
- SENATE3 reports
- White House Office2 reports
- Commerce, Dept of (DOC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Akin Gump Strauss Hauer & Feld | $210K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/19for Q2 2024 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 24/04/19for Q1 2024 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 24/01/19for Q4 2023 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 23/10/20for Q3 2023 | Akin Gump Strauss Hauer & Feld | $80K |
| 23/07/20for Q2 2023 | Akin Gump Strauss Hauer & Feld | $80K |
| 23/04/20for Q1 2023 | Akin Gump Strauss Hauer & Feld | $50K |
| 23/03/31for Q1 2023 | Akin Gump Strauss Hauer & Feld | Under $5,000 |